Table 3.
Ala/Thr vs Ala/Ala | Ala/Thr vs Thr/Thr | Thr/Thr vs Ala/Ala | Ala/Thr vs Ala/Ala + Thr/Thr (Overdominant model) |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OR* | CI 95% | P | OR* | CI 95% | P | OR* | CI 95% | P | OR* | CI 95% | P | ||||
Mortality | 0.52 | 0.18-1.75 | .26 | 0.49 | 0.23-1.04 | 0.06 | 1.06 | 0.36-3.57 | .9 | 0.52 | 0.26-1.04 | 0.07 | |||
Model 5 | Model 4 | Model 1 | Male gender | 0.52 | 0.18-1.76 | .26 | 0.49 | 0.23-1.04 | 0.06 | 1.06 | 0.36-3.57 | .9 | 0.52 | 0.26–1.04 | 0.07 |
Age > 60 year | 0.53 | 0.18-1.79 | .27 | 0.50 | 0.23-1.06 | 0.07 | 1.07 | 0.36-3.59 | .9 | 0.53 | 0.26–1.06 | 0.07 | |||
Diabetes | 0.48 | 0.16-1.62 | .20 | 0.45 | 0.21-0.98 | 0.04 | 1.05 | 0.36-3.53 | .9 | 0.49 | 0.23–0.98 | 0.047 | |||
Hypertension | 0.52 | 0.18-1.75 | .26 | 0.49 | 0.23-1.06 | 0.07 | 1.05 | 0.36-3.55 | .9 | 0.53 | 0.26–1.06 | 0.08 | |||
Hospital stay | 0.47 | 0.15-1.65 | .21 | 0.48 | 0.21-1.07 | 0.07 | 0.97 | 0.32-3.39 | 1.0 | 0.51 | 0.24–1.05 | 0.07 | |||
Model 1 | 0.43 | 0.14-1.54 | .17 | 0.43 | 0.19-0.99 | 0.048 | 0.99 | 0.32-3.51 | 1.0 | 0.46 | 0.21–0.98 | 0.046 | |||
Model 2 | TSH | 0.51 | 0.17-1.72 | .24 | 0.49 | 0.23-1.03 | 0.06 | 1.04 | 0.35-3.51 | .9 | 0.52 | 0.26–1.05 | 0.07 | ||
Free T3 | 0.74 | 0.24-2.65 | .62 | 0.54 | 0.25-1.16 | 0.12 | 1.37 | 0.44-4.87 | .6 | 0.62 | 0.3–1.28 | 0.20 | |||
Free T4 | 0.51 | 0.17-1.74 | .25 | 0.49 | 0.23-1.03 | 0.06 | 1.06 | 0.36-3.55 | .9 | 0.52 | 0.25–1.04 | 0.07 | |||
Reverse T3 | 0.48 | 0.16-1.66 | .22 | 0.54 | 0.25-1.17 | 0.12 | 0.89 | 0.29-3.07 | .8 | 0.56 | 0.27–1.13 | 0.11 | |||
Model 2 | 0.61 | 0.19-2.24 | .42 | 0.56 | 0.25-1.22 | 0.14 | 0.92 | 0.25-1.22 | .9 | 0.64 | 0.3–1.32 | 0.23 | |||
Model 3 | IL-6 | 0.51 | 0.17-1.73 | .25 | 0.49 | 0.23-1.04 | 0.06 | 1.05 | 0.26-3.52 | .9 | 0.52 | 0.25–1.04 | 0.07 | ||
CRP | 0.55 | 0.16-2.19 | .36 | 0.41 | 0.18-0.9 | 0.03 | 1.34 | 0.4-5.36 | .6 | 0.46 | 0.21–0.96 | 0.04 | |||
D-DIMER | 0.57 | 0.19-1.97 | .34 | 0.51 | 0.23-1.11 | 0.09 | 1.12 | 0.37-3.85 | .9 | 0.55 | 0.27–1.13 | 0.11 | |||
Neutrophil | 0.47 | 0.16-1.61 | .20 | 0.44 | 0.2-0.96 | 0.04 | 1.06 | 0.36-3.59 | .9 | 0.48 | 0.23–0.97 | 0.04 | |||
LDH | 0.46 | 0.15-1.58 | .19 | 0.47 | 0.21-1.05 | 0.07 | 0.97 | 0.32-3.33 | 1.0 | 0.49 | 0.23–1.03 | 0.06 | |||
Model 3 | 0.52 | 0.14-2.2 | .34 | 0.36 | 0.15-0.85 | 0.02 | 1.44 | 0.41-6.08 | .6 | 0.42 | 0.18–0.92 | 0.03 | |||
Model 4 | 0.46 | 0.12-2.04 | .27 | 0.32 | 0.12-0.8 | 0.02 | 1.43 | 0.38-6.41 | .6 | 0.38 | 0.16–0.87 | 0.03 | |||
Model 5 | 0.56 | 0.13-2.85 | .46 | 0.32 | 0.12-0.85 | 0.03 | 1.74 | 0.4-9.02 | .5 | 0.40 | 0.16–0.98 | 0.049 |
Multivariable regression analyses: Model 1, adjusted for male gender, age >60 years, diabetes, arterial hypertension, and length of hospital stay. Model 2, adjusted for thyrotropin, free triiodothyronine, free thyroxine, and reverse triiodothyronine. Model 3, adjusted for interleukin-6, neutrophils, lactate dehydrogenase, C-reactive protein, and D-dimer. Model 4, adjusted for Model 1 and 3. Model 5, adjusted for all of the above variables.